| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Association between publication of appropriate use criteria and the temporal trends in diagnostic angiography in stable coronary artery disease: A population-based study
|
Arbel, Yaron
|
|
2016
|
175 |
C |
p. 153-159
7 p.
|
article
|
| 2 |
Bivalirudin versus heparin in non-ST and ST-segment elevation myocardial infarction—a registry-based randomized clinical trial in the SWEDEHEART registry (the VALIDATE-SWEDEHEART trial)
|
Erlinge, David
|
|
2016
|
175 |
C |
p. 36-46
11 p.
|
article
|
| 3 |
Changes in cardiovascular risk factors after 5 years of implementation of a population-based program to reduce cardiovascular disease: The Heart of New Ulm Project
|
Sidebottom, Abbey C.
|
|
2016
|
175 |
C |
p. 66-76
11 p.
|
article
|
| 4 |
Comparison of performance on Hospital Compare process measures and patient outcomes between hospitals that do and do not participate in Acute Coronary Treatment and Intervention Outcomes Network Registry–Get With The Guidelines
|
Mathews, Robin
|
|
2016
|
175 |
C |
p. 1-8
8 p.
|
article
|
| 5 |
Corrigendum to ’The Brazilian Cardioprotective Nutritional Program to reduce events and risk factors in secondary prevention for cardiovascular disease: study protocol (The BALANCE Program Trial)’ [American Heart Journal 171/1 (2016) 73–81]
|
Weber, Bernardete
|
|
2016
|
175 |
C |
p. 202-203
2 p.
|
article
|
| 6 |
Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trial
|
Berger, Jeffrey S.
|
|
2016
|
175 |
C |
p. 86-93
8 p.
|
article
|
| 7 |
Directions for future trials on blood glucose-lowering drugs to improve left ventricular function post–ST-segment elevation myocardial infarction
|
van Dijk, Peter Ruben
|
|
2016
|
175 |
C |
p. e1-
1 p.
|
article
|
| 8 |
Do stable non–ST-segment elevation acute coronary syndromes require admission to coronary care units?
|
van Diepen, Sean
|
|
2016
|
175 |
C |
p. 184-192
9 p.
|
article
|
| 9 |
Editorial Board
|
|
|
2016
|
175 |
C |
p. A5-
1 p.
|
article
|
| 10 |
Family history of atrial fibrillation is associated with earlier-onset and more symptomatic atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry
|
Gundlund, Anna
|
|
2016
|
175 |
C |
p. 28-35
8 p.
|
article
|
| 11 |
Genetic loci associated with ideal cardiovascular health: A meta-analysis of genome-wide association studies
|
Allen, Norrina B.
|
|
2016
|
175 |
C |
p. 112-120
9 p.
|
article
|
| 12 |
History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial
|
De Caterina, Raffaele
|
|
2016
|
175 |
C |
p. 175-183
9 p.
|
article
|
| 13 |
Hospital triage of acute myocardial infarction: Is admission to the coronary care unit still necessary?
|
Silverman, Michael G.
|
|
2016
|
175 |
C |
p. 172-174
3 p.
|
article
|
| 14 |
Impact of genetic variants on the upstream efficacy of renin-angiotensin system inhibitors for the prevention of atrial fibrillation
|
Roberts, Jason D.
|
|
2016
|
175 |
C |
p. 9-17
9 p.
|
article
|
| 15 |
Impact of severe lesion calcification on clinical outcome of patients with stable angina, treated with newer generation permanent polymer-coated drug-eluting stents
|
Huisman, Jennifer
|
|
2016
|
175 |
C |
p. 121-129
9 p.
|
article
|
| 16 |
Information for Readers
|
|
|
2016
|
175 |
C |
p. A6-
1 p.
|
article
|
| 17 |
Ischemic cardiac outcomes and hospitalizations according to prior macrovascular disease status in patients with type 2 diabetes and recent acute coronary syndrome from the Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care trial
|
Shimada, Yuichi J.
|
|
2016
|
175 |
C |
p. 18-27
10 p.
|
article
|
| 18 |
Patient and physician discordance in reporting symptoms of angina among stable coronary artery disease patients: Insights from the Angina Prevalence and Provider Evaluation of Angina Relief (APPEAR) study
|
Shafiq, Ali
|
|
2016
|
175 |
C |
p. 94-100
7 p.
|
article
|
| 19 |
Prior bleeding, future bleeding and stroke risk with oral anticoagulation in atrial fibrillation: What new lessons can ARISTOTLE teach us?
|
Goodman, Shaun G.
|
|
2016
|
175 |
C |
p. 168-171
4 p.
|
article
|
| 20 |
Rationale and design of a home-based trial using wearable sensors to detect asymptomatic atrial fibrillation in a targeted population: The mHealth Screening To Prevent Strokes (mSToPS) trial
|
Steinhubl, Steven R.
|
|
2016
|
175 |
C |
p. 77-85
9 p.
|
article
|
| 21 |
Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non–ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction
|
Pilgrim, Thomas
|
|
2016
|
175 |
C |
p. 56-65
10 p.
|
article
|
| 22 |
Sex-related differences in left ventricular remodeling in severe aortic stenosis and reverse remodeling after aortic valve replacement: A cardiovascular magnetic resonance study
|
Dobson, Laura E.
|
|
2016
|
175 |
C |
p. 101-111
11 p.
|
article
|
| 23 |
Table of Contents
|
|
|
2016
|
175 |
C |
p. A1-A4
nvt p.
|
article
|
| 24 |
Ten-year clinical outcomes after sirolimus-eluting stent implantation: Impact of an in-stent restenosis target lesion
|
Miura, Katsuya
|
|
2016
|
175 |
C |
p. 47-55
9 p.
|
article
|
| 25 |
The China Acute Myocardial Infarction (CAMI) Registry: A national long-term registry-research-education integrated platform for exploring acute myocardial infarction in China
|
Xu, Haiyan
|
|
2016
|
175 |
C |
p. 193-201.e3
200808 p.
|
article
|
| 26 |
The impact of drug shortages on patients with cardiovascular disease: causes, consequences, and a call to action
|
Reed, Brent N.
|
|
2016
|
175 |
C |
p. 130-141
12 p.
|
article
|
| 27 |
The optimal definition of contrast-induced acute kidney injury for prediction of inpatient mortality in patients undergoing percutaneous coronary interventions
|
Parsh, Jessica
|
|
2016
|
175 |
C |
p. 160-167
8 p.
|
article
|
| 28 |
Utility of positron emission tomography for drug development for heart failure
|
Papadimitriou, Lampros
|
|
2016
|
175 |
C |
p. 142-152
11 p.
|
article
|
Journal description